Conditional reduction of human immunodeficiency virus type 1 replication by a gain-of-herpes simplex virus 1 thymidine kinase function.

The development of an effective vaccine for human immunodeficiency virus type 1 (HIV-1) would be a major advance toward controlling the AIDS pandemic. Several disparate strategies for a safe and effective HIV vaccine have been proposed. Recent data suggest that loss-of-function live-attenuated virus...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Proc Natl Acad Sci U S A
Principais autores:	Smith, S M, Markham, R B, Jeang, K T
Formato:	Artigo
Idioma:	Inglês
Publicado em:	National Academy of Sciences 1996
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC38856/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8755584/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.93.15.7955
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!